Platelet gel in the treatment of cutaneous ulcers: The experience of the Immunohaematology and Transfusion Centre of Parma

Blood Transfusion

Volumn 8, Issue 4, 2010, Pages 237-247

  Bernuzzi, Gino ^a   Tardito, Saverio ^b   Bussolati, Ovidio ^b   Adorni, Daniela ^a   Cantarelli, Stefano ^a   Fagnoni, Francesco ^a   Rossetti, Angelo ^a   Azzarone, Matteo ^a   Ficarelli, Elena ^a   Caleffi, Edoardo ^a   Gazzola, Giancarlo ^b   Franchini, Massimo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Cell proliferation; Fibroblasts; Platelet gel; Ulcers

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; GLUCONATE CALCIUM; ILOPROST; THROMBIN; THROMBOCYTE CONCENTRATE;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; BLOOD COMPONENT; BLOOD COMPONENT THERAPY; BLOOD DONOR; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER FLOWMETRY; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METABOLIC ACTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PLATELET GEL; PROTEIN SYNTHESIS; SKIN SURGERY; SKIN ULCER; STANDARDIZATION; SURGICAL TECHNIQUE; THERAPY EFFECT; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GELS; HUMANS; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; PROLINE; PROTEIN BIOSYNTHESIS; SKIN ULCER; TREATMENT OUTCOME;

EID: 78049301679     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2009.0118-09     Document Type: Article

References (30)

1. Reiber GE, Raugi GJ. Preventing foot ulcers and amputations in diabetes. Lancet 2005; 366: 1676-7.
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-24. (Pubitemid 41587452)
3. Vande Berg JS, Robson MC. Arresting cell cycles and the effect on wound healing. Surg Clin North Am 2003; 83: 509-20.
4. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 2004; 30: 145-51.
5. Mazzucco L, Medici D, Serra M, et al. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004; 44: 1013-8.
6. Everts PA, Overdevest EP, Jakimowicz JJ, et al. The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review. Surg Endosc 2007; 21: 2063-8.
7. Caloprisco G, Borean A, Mele A. Lezioni del VII Corso di aggiornamento in Emaferesi. SIdEM 2002.
8. Driver VR, Hanft J, Fylling CP, et al. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006; 52: 68-70, 72, 74 passim.
9. Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care 2008; 21: 568-75.
10. Everts PA, Hoffmann J, Weibrich G, et al. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 2006; 16: 363-8. (Pubitemid 44453759)
11. Mazzucco L, Balbo V, Cattana E, et al. Not every PRP-gel is born equal Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009; 97: 110-8.
12. Waters JH, Roberts KC. Database review of possible factors influencing point-of-care platelet gel manufacture. J Extra Corpor Technol 2004; 36: 250-4.
13. Valeri CR, Saleem B, Ragno G. Release of platelet-derived growth factors and proliferation of fibroblasts in the releasates from platelets stored in the liquid state at 22 degrees C after stimulation with agonists. Transfusion 2006; 46: 225-9.
14. Kevy SV, Jacobson MS. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol 2004; 36: 28-35.
15. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004; 114: 1502-8.
16. Wildemann B, Kadow-Romacker A, Haas NP, et al. Quantification of various growth factors in different demineralized bone matrix preparations. J Biomed Mater Res A 2007; 81: 437-42. (Pubitemid 46668858)
17. Ficarelli E, Bernuzzi G, Tognetti E, et al. Treatment of chronic venous leg ulcers by platelet gel. Dermatol Ther 2008; 21 (Suppl 1): S13-7.
18. Franchi-Gazzola R, Visigalli R, Dall'Asta V, et al. Amino acid depletion activates TonEBP and sodium-coupled inositol transport. Am J Physiol Cell Physiol 2001; 280: C1465-74.
19. O'Brien J, Wilson I, Orton T, et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000; 267: 5421-6.
20. Franchi-Gazzola R, Gaccioli F, Bevilacqua E, et al. The synthesis of SNAT2 transporters is required for the hypertonic stimulation of system A transport activity. Biochim Biophys Acta 2004; 1667: 157-66.
21. Bianchi MG, Gazzola GC, Tognazzi L, et al. C6 glioma cells differentiated by retinoic acid overexpress the glutamate transporter excitatory amino acid carrier 1 (EAAC1). Neuroscience 2008; 151: 1042-52.
22. Rozen S SH. Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 2000 132 365-86.
23. Bustin SA. Absolute quantification of mRNA using realtime reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169-93.
24. Gaccioli F, Huang CC, Wang C, et al. Amino acid starvation induces the SNAT2 neutral amino acid transporter by a mechanism that involves eukaryotic initiation factor 2alpha phosphorylation and cap-independent translation. J Biol Chem 2006; 281: 17929-40.
25. Franchi-Gazzola R, Dall'Asta V, Sala R, et al. The role of the neutral amino acid transporter SNAT2 in cell volume regulation. Acta Physiol (Oxf) 2006; 187: 273-83. (Pubitemid 43828785)
26. Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997; 77: 575-86.
27. Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996; 41: 159-67.
28. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009; 17: 153-62.
29. Bielecki TM, Gazdzik TS, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg Br 2007; 89: 417-20. (Pubitemid 46563928)
30. Della Corte A, Maugeri N, Pampuch A, et al. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008; 19: 43-5